MapLight Therapeutics chief scientific officer sells $93,025 in shares
Covered in this story
What has happened since
- Maplight Therapeutics Inc is up 7.1% since this was published, 6 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Maplight Therapeutics Inc
- Morgan Stanley: $9.9 → $21 by Jul 2027 · Equalweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MPLT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Maplight Therapeutics Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.